Anlotinib, by inhibiting targets such as c-Kit (proliferation), RET (proliferation), FGFR (proliferation/metastasis), and c-Met (metastasis), has been demonstrated to control tumor cell proliferation and metastasis[11]. Here, MET is linked to neoplasm.